Involving American Indians and medically underserved rural populations in cancer clinical trials
Authors:
- 23 November 2009
- journal article
- other
- Published by SAGE Publications in Clinical Trials
- Vol. 6 (6) , 610-617
Abstract
Purpose To assess cancer clinical trial recruitment and reasons for nonaccrual among a rural, medically underserved population served by a community-based cancer care center. Methods We prospectively tracked clinical trial enrollment incidence among all new patients presenting at the Rapid City Regional Cancer Care Institute. Evaluating physicians completed questionnaires for each patient regarding clinical trial enrollment status and primary reasons for nonenrollment. Patients who identified as American Indian were referred to a program where patients were assisted in navigating the medical system by trained, culturally competent staff. Results Between September 2006 and January 2008, 891 new cancer patients were evaluated. Seventy-eight patients (9%; 95% confidence intervals, 7—11%) were enrolled on a clinical treatment trial. For 73% (95% confidence intervals, 69—75%) of patients (646 of 891) lack of relevant protocol availability or protocol inclusion criteria restrictiveness was the reason for nonenrollment. Only 45 (5%; 95% confidence intervals, 4—7%) patients refused enrollment on a trial. Of the 78 enrolled on a trial, 6 (8%; 95% confidence intervals, 3—16%) were American Indian. Three additional American Indian patients were enrolled under a nontreatment cancer control trial, bringing the total percentage enrolled of the 94 American Indians who presented to the clinic to 10% (95% confidence intervals, 5—17%). Limitations Eligibility rates were unable to be calculated and cross validation of the number in the cohort via registries or ICD-9 codes was not performed. Conclusion Clinical trial participation in this medically underserved population was low overall, but approximately 3-fold higher than reported national accrual rates. Lack of availability of protocols for common cancer sites as well as stringent protocol inclusion criteria were the primary obstacles to clinical trial enrollment. Targeted interventions using a Patient Navigation program were used to engage AI patients and may have resulted in higher clinical trial enrollment among this racial/ethnic group. Clinical Trials 2009; 6: 610—617. http://ctj.sagepub.comKeywords
This publication has 32 references indexed in Scilit:
- Medical Mistrust and Less Satisfaction With Health Care Among Native Americans Presenting for Cancer TreatmentJournal Of Health Care For The Poor and Underserved, 2009
- Practical Clinical TrialsJAMA, 2003
- Barriers to the participation of African‐American patients with cancer in clinical trialsCancer, 2003
- Differences in Breast Cancer Stage, Treatment, and Survival by Race and EthnicityArchives of internal medicine (1960), 2003
- Distrust, Race, and ResearchArchives of internal medicine (1960), 2002
- Cancer Survival Among US Whites and MinoritiesArchives of internal medicine (1960), 2002
- Selection and description of cancer clinical trials participants—Science or happenstance?Cancer, 2002
- How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsJournal of Clinical Oncology, 2002
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2002
- Prospective Evaluation of Cancer Clinical Trial Accrual Patterns: Identifying Potential Barriers to EnrollmentJournal of Clinical Oncology, 2001